Abbott Laboratories (NYSE:ABT)

Abbott is a global healthcare company devoted to improving life through the development of products and technologies that span the breadth of healthcare.  They have a portfolio of leading, science-based offerings in diagnostics, medical devices, nutritionals and branded generic pharmaceuticals.

Abbott Laboratories (NYSE:ABT)’s Financial Overview

Abbott Laboratories (NYSE:ABT) declined -0.03% yesterday to close its trading session at $38.73. The company has 1 year Price Target of $47.38. Abbott Laboratories has 52-Week high of $46.22 and 52-Week Low of $36. The stock touched its 52-Week High on Dec 17, 2015 and 52-Week Low on Jan 28, 2016. The stock traded with the volume of 7.24 Million shares yesterday. The firm shows the market capitalization of $57.02 Billion.

Abbott Laboratories (NYSE:ABT) reported its last quarterly earnings on Sep 16 where the firm reported its Actual EPS of $0.59/share against the analyst consensus estimate of $0.58/share. The difference between the actual and expected EPS is $0.01 a share with a surprise factor of 1.7%.

The firm is trading with SMA20 of -1.81 Percent, SMA50 of -4.52 Percent and SMA200 of -4.34 percent. Abbott Laboratories has P/S value of 2.75 while its P/B value stands at 2.75. Similarly, the company has Return on Assets of 3.4 percent, Return on Equity of 6.6 percent and Return on Investment of 7.7 Percent. The company shows Gross Margin and Operating Margin of 56.9 percent and 14.7 percent respectively.

Many brokerage firms are involved in issuing their ratings on Abbott Laboratories (NYSE:ABT). On 21-Jun-16 Edward Jones Upgrade Abbott Laboratories Stock  to Buy. Another firm also rated the stock on 4-Jan-16 where Morgan Stanley Downgrade the stock to Equal-Weight.

The Stock currently has Analyst’ mean Recommendation of 1.9 where the scale is from 1 to 5, 1 means Strong Buy and 5 means Sell.

The 13 analysts offering 12-month price forecasts for Abbott Laboratories have a median target of 48.00, with a high estimate of 50.00 and a low estimate of 43.00. The median estimate represents a +23.93% increase from the last price of 38.73.

Our vendor, Zacks Investment Research, hasn’t provided us with the upcoming earnings report date.

Cognizant Technology Solutions Corporation (NASDAQ:CTSH)

Cognizant Technology Solutions delivers high-quality, cost-effective, full life cycle solutions to complex software development and maintenance  problems that companies face as they transition to e-business.  These  services are delivered through the use of a seamless on-site and offshore consulting project team. The company’s solutions include application  development and integration, application management, re-engineering, and mass change services.

Cognizant Technology Solutions Corporation (NASDAQ:CTSH)’s Financial Outlook

The 30 analysts offering 12-month price forecasts for Cognizant Technology Solutions Corp have a median target of 64.50, with a high estimate of 75.00 and a low estimate of 49.00. The median estimate represents a +15.94% increase from the last price of 55.63.

Our vendor, Zacks Investment Research, hasn’t provided us with the upcoming earnings report date.

According to Zacks Investment Research, Cognizant Technology Solutions Corporation has a Consensus Recommendation of 2. (The Scale is from 1-5 where 1 means Strong Buy and 5 means Strong Sell).

The Stock fell -2.32% and closed its last trading session at $55.63. The company has the market capitalization of $33.75 Billion. The stock has 52-week high of $65.2 and 52-Week low of $45.44. The firm touched its 52-Week high on Dec 2, 2015 and 52-Week low on Sep 30, 2016. The company has volume of 7.22 Million shares. The company has a total of 606.7 Million shares outstanding.

Cognizant Technology Solutions Corporation (NASDAQ:CTSH) in the last quarter reported its actual EPS of $0.86/share where the analyst estimated EPS was $0.84/share. The difference between the actual and Estimated EPS is $0.02. This shows a surprise factor of 2.4 percent.

The company has YTD performance of -7.31 percent. Beta for Cognizant Technology Solutions Corporation stands at 1.3 while its ATR (average true range) is 1.69. The company has Weekly Volatility of 2.64%% and Monthly Volatility of 2.44%%.

Cognizant Technology Solutions Corporation has distance from 20-day Simple Moving Average (SMA20) of 3.58%, Distance from 50-Day Simple Moving Average of 6.21 percent and Distance from 200-Day Simple Moving Average of -2.8%.

The Company currently has ROA (Return on Assets) of 11.9 percent, Return on Equity (ROE) of 16 Percent and Return on Investment (ROI) of 15.2% with Gross margin of 40.4 percent and Operating & Profit margin of 17.2% and 11.8% respectively.

 

SHARE